Funded Local Who is raising money in your own backyard?

NxtGen Emission Controls Inc. announced today the closing of a $15.4 million USD Series B investment led by Altira Group LLC.

NxtGen is an emerging leader in syngas technology for diesel engine combustion optimization. NxtGen’s technology is making existing and new engines cleaner to meet global emission reduction regulations. It provides a platform for advanced emission and combustion technologies for multiple fuels, including diesel, biodiesel, natural gas and gasoline.

The announcement was made by Jeremy Holt, president and chief executive officer of NxtGen.

Brossard, QC, June 27, 2008– Railpower Technologies Corp. (TSX: P) (the “Corporation”) is pleased to announce that it has closed its previously announced $20 Million private placement with Teachers. The proceeds will be used to finance, among other things, construction of a manufacturing facility in Saint- Jean-sur-Richelieu.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, BC – Inimex Pharmaceuticals, Inc. is pleased to announce the closing of a US $22 Million Series B venture financing. Leading the round was Morningside Venture Investments Ltd., joined by additional new investors Roche Venture Fund, Switzerland, CA-based Astellas Venture Management LLC, the corporate venture capital arm of Astellas Pharma Inc. in Japan, and BC-based Advantage Life Science Fund II.

Vancouver BC, December 13, 2007 - Zeugma Systems Inc., a company developing a telecommunications system for next generation high speed broadband networks, today announced completion of its US$22.5 million Series B financing.

The financing was led by new investor Vertex Venture Capital. The syndicate members include returning investors Granite Ventures, Ventures West, Yaletown Venture Partners, GrowthWorks Capital Ltd. and BDC Venture Capital, as well as new investors GTD Capital and BC Advantage Funds.

Calgary, AB, November 8, 2007 - 1322256 Alberta Ltd. (the “Company”; formerly Inex Pharmaceuticals Corporation), is pleased to announce the closing of a non-brokered private placement consisting of 222,727,273 common shares for gross proceeds of $12,250,000 at a price of $0.055 per share (the "Offering").

Net proceeds from the Offering will be used to fund business development activities as the Company seeks new opportunities to deploy its capital. Officers and directors of the Company participated in the Offering for $4,287,500 (77,954,545 shares).

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2007) - Inflazyme Pharmaceuticals Ltd. (TSX:IZP) and Biolipox AB, a private Swedish pharmaceutical company, today announced that they have entered into a definitive asset purchase agreement whereby Biolipox will acquire the majority of Inflazyme's assets for potential gross proceeds of up to $11 million plus a potential royalty payment. The assets include Inflazyme's research and development programs on the LSAIDs(TM), the PDE inhibitors and the Protein Therapeutics Technology.

It is official -
Proceeds will be used to continue to expand its leadership in the market for behavioral targeted online advertising

Vancouver, British Columbia and San Francisco, California - August 1, 2007, Adzilla Inc. is pleased to announce that it has successfully completed a USD $10.25 million Series A financing from two Silicon Valley venture capital firms, Norwest Venture Partners and Alloy Ventures.

Vancouver, B.C. and New York, NY – July 30, 2007 – NowPublic.com, the world’s largest participatory news network, today announced that it closed a $10.6 million Series A financing, led by Rho Ventures, based in New York and Palo Alto and its affiliate Rho Canada, based in Montreal. The round also includes two other venture firms, Brightspark and the Working Opportunity Fund, managed by GrowthWorks Capital Ltd., both of which participated as seed investors.

VANCOUVER, July 23 /CNW/ - Response Biomedical Corporation (TSX-V: RBM,
OTCBB: RPBIF) today announced that the Company has closed the financing
announced July 9, 2007, raising gross proceeds of $12 million. The financing
was a bought deal private placement, under which the Company issued 12,000,000
common shares at a price of $1.00 for each common share.
Haywood Securities Inc., the sole underwriter for this offering, was paid
a commission of seven percent of the gross proceeds in connection with the
financing. The common shares issued under the private placement will have a